Goodenowe is not a medical doctor, but he does have a PhD in medical science with a focus on psychiatry. He’s a listed author ...

Iran's nuclear program remains a top focus for inspectors from the International Atomic Energy Agency, particularly as any possible deal between Tehran and the United States over ...

President Donald Trump on Friday called Elon Musk “the man who has lost his mind” and told ABC News that he is “not ...

On May, 28, the FDA marked the tomato recall affecting three states as Class I, meaning there is a risk of "serious adverse health consequences or death." The tomato recall, initiated by ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

Welcome to hurricane season 2025. There are no signs of tropical development across the Atlantic, Caribbean and Gulf for the next week, at least. Even the long-range forecasts show low odds of ...

I expect it, I'm told,## in Congress next week. And# we will follow that closely. GEOFF BENNETT: Lisa Desjardins,# our thanks to you, as always. LISA DESJARDINS: You're welcome.

The Langhorne, Pa., biopharmaceutical company said Tuesday it received a refusal-to-file letter from the FDA for the biologics license application for Molbreevi as a therapy to treat patients with ...

The FDA has slapped Savara with a refuse to file (RTF) letter after the biotech in March applied for approval of molgramostim in the rare disease autoimmune pulmonary alveolar proteinosis (aPAP).

The FDA cleared an investigational new drug application for AVZO-1418/DB-1418, and a phase 1/2 trial in advanced solid tumors will begin later this year. The FDA has cleared the investigational new ...